Company
United StatesPublic company, NASDAQ: CGONCG Oncology, Inc. (NASDAQ: CGON), Irvine, CA – FDA Inspections
Inspection records and compliance data for CG Oncology, Inc. in Irvine, California. 1 FDA inspection on record, last inspected September 02, 2022. Publicly traded as NASDAQ: CGON.
Company Profile
This profile covers CG Oncology, Inc. based in Irvine, California, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected September 2, 2022.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 2, 2022 | NAI | Biologics · Bioresearch Monitoring | 1179721 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
CG Oncology, Inc.
Stock ticker
CGON
Exchange
NASDAQ
Share price
$64.79
Market cap
$5.7B
Price as of
November 6, 2026
FEI Number
3016721233
Address
400 Spectrum Center Dr Ste 2040, Irvine, California 92618, United States
Country
United States
ID: a0e5699f-7b8d-4125-b528-3e9b2f7014f4